Project Scope This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies. |
| Project Leads | Emails |
|---|---|
| Mary Nilsson (Eli Lilly) | |
| Greg Ball (Novavax) | gball@novavax.com |
| Katie Warren (PHUSE Project Assistant) | katie@phuse.global |
| Objectives & Deliverables |
|---|
| White Paper |
| Journal Article |
| ||||||
|---|---|---|---|---|---|---|
| Project approved Q2 2022. |
| Project Members | Organisation |
|---|---|
| Barbara Hendrickson | Abbvie |
| Brian Panik | MedAssessment |
| Charles Beasley | Independent |
| Clio Wu | Chinook Therapeutics |
| Emily Goren | Seagen |
| Jyoti Agarwal | Gilead |
| Hannah Palac | AbbVie |
| Karen Wade | Rhoworld |
| Ketan Durve | Janssen Research & Development |
| Kimberly Umans | Biogen |
| Mac Gordon | Johnson & Jhonson |
| Mengchun Li | TB Alliance |
Mika Tsujimoto | Eli Lilly |
| Nhi Beasley | FDA |
| Peg Fletcher | MedAssessment |
| Pranav Soanker | Pfizer |
| Ramaiah Muvvala | Inductive Quotient |
| Rebeka Revis | IQVIA |
| Scott Proestel | FDA |
| Shayami Thanabalasundrum | Exelixis |
| Sunil Kumar Shantharaju | Boehringer |
| Suwen Li | Roche |
| William Palo | Abbvie |
| Ying (Heather) Hao | Prothena |
| Vaishali Popat | FDA |